Esters of (+)-alpha-(2,3-dimethoxyphenyl-[2-(4-flurophenyl) ethyl]-4-piperidinemethanol and their use as prodrugs of the 5HT2a receptor antagonist MDL 110,907
A Standard patent application filed on 09 March 2004 credited to Carr, Albert A.
;
Van Hijfte, Luc E.
;
Kosley, Jr Raymond W.
Details
Application number :
2004200993
Application type :
Standard
Application status :
LAPSED
Under opposition :
No
Proceeding type :
Invention title :
Esters of (+)-alpha-(2,3-dimethoxyphenyl-[2-(4-flurophenyl) ethyl]-4-piperidinemethanol and their use as prodrugs of the 5HT2a receptor antagonist MDL 110,907
Inventor :
Carr, Albert A.
;
Van Hijfte, Luc E.
;
Kosley, Jr Raymond W.
Agent name :
Watermark Patent and Trade Marks Attorneys
Address for service :
Level 2 302 Burwood Road Hawthorn VIC 3122 Australia
Filing date :
09 March 2004
Associated companies :
Applicant name :
Aventis Pharmaceuticals Inc.
Applicant address :
55 Corporate Drive Bridgewater New Jersey 08807 United States of America